Teresa Coelho

15.5k total citations · 3 hit papers
162 papers, 5.5k citations indexed

About

Teresa Coelho is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Teresa Coelho has authored 162 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Molecular Biology, 43 papers in Physiology and 36 papers in Cell Biology. Recurrent topics in Teresa Coelho's work include Amyloidosis: Diagnosis, Treatment, Outcomes (142 papers), Dermatological and Skeletal Disorders (30 papers) and Cellular transport and secretion (30 papers). Teresa Coelho is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (142 papers), Dermatological and Skeletal Disorders (30 papers) and Cellular transport and secretion (30 papers). Teresa Coelho collaborates with scholars based in Portugal, United States and France. Teresa Coelho's co-authors include Ole B. Suhr, David Adams, Laura Obici, Alda Sousa, Mathew S. Maurer, Violaine Planté‐Bordeneuve, John L. Berk, Márcia Waddington‐Cruz, Isabel Conceição and Michel Slama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Teresa Coelho

154 papers receiving 5.4k citations

Hit Papers

Guideline of transthyretin-related hereditary amyloidosis... 2013 2026 2017 2021 2013 2019 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guideline of transthyretin-related hereditary amyloidosis for clinicians
    2013 493 citations Teresa Coelho, John L. Berk et al. Orphanet Journal of Rare Diseases profile →
  2. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease
    2019 288 citations David Adams, Haruki Koike et al. profile →
  3. Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
    2022 218 citations David Adams, Teresa Coelho et al. Amyloid profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teresa Coelho Portugal 39 5.0k 1.2k 998 936 866 162 5.5k
Masahide Yazaki Japan 33 2.5k 0.5× 304 0.3× 377 0.4× 339 0.4× 561 0.6× 158 3.3k
Toya Ohashi Japan 38 2.0k 0.4× 676 0.6× 590 0.6× 372 0.4× 85 0.1× 198 4.6k
Emil Kakkis United States 37 1.1k 0.2× 598 0.5× 582 0.6× 182 0.2× 342 0.4× 73 5.0k
Johannes Schlöndorff United States 23 1.8k 0.4× 354 0.3× 320 0.3× 759 0.8× 904 1.0× 39 3.2k
Gilbert J. Cote United States 46 3.3k 0.7× 220 0.2× 912 0.9× 1.5k 1.6× 127 0.1× 141 7.3k
Philippe M. Campeau Canada 33 1.8k 0.4× 298 0.3× 1.0k 1.1× 304 0.3× 51 0.1× 123 3.3k
David B. Bregman United States 28 1.9k 0.4× 433 0.4× 279 0.3× 326 0.3× 334 0.4× 43 3.3k
Wadie F. Bahou United States 36 1.5k 0.3× 312 0.3× 264 0.3× 686 0.7× 67 0.1× 95 4.3k
Yoko Aoki Japan 36 2.9k 0.6× 562 0.5× 777 0.8× 581 0.6× 21 0.0× 170 4.8k
Terence Wu United States 29 2.0k 0.4× 334 0.3× 227 0.2× 1.8k 1.9× 261 0.3× 44 3.3k

Countries citing papers authored by Teresa Coelho

Since Specialization
Citations

This map shows the geographic impact of Teresa Coelho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Coelho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Coelho more than expected).

Fields of papers citing papers by Teresa Coelho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Coelho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Coelho. The network helps show where Teresa Coelho may publish in the future.

Co-authorship network of co-authors of Teresa Coelho

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Coelho. A scholar is included among the top collaborators of Teresa Coelho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Coelho. Teresa Coelho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monteiro, Cecília, Teresa Coelho, James J. Moresco, et al.. (2025). Plasma Proteome Profiling Reveals Inflammation Markers and Tafamidis Effects in V30M Transthyretin Polyneuropathy. International Journal of Molecular Sciences. 26(12). 5534–5534.
2.
3.
Conceição, Isabel, John L. Berk, Markus Weiler, et al.. (2024). Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform. Journal of Neurology. 271(10). 6655–6666. 4 indexed citations
4.
5.
Coelho, Teresa, et al.. (2024). A IMPORTÂNCIA DO PLANEJAMENTO EDUCACIONAL INDIVIDUAL NA EDUCAÇÃO INCLUSIVA. Aracê.. 6(3). 5750–5762.
6.
Waddington‐Cruz, Márcia, Yoshiki Sekijima, Haruki Koike, et al.. (2023). Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal. Orphanet Journal of Rare Diseases. 18(1). 323–323. 6 indexed citations
7.
Rocha, Ana Patrícia, et al.. (2021). Supporting the Assessment of Hereditary Transthyretin Amyloidosis Patients Based On 3-D Gait Analysis and Machine Learning. IEEE Transactions on Neural Systems and Rehabilitation Engineering. 29. 1350–1362. 8 indexed citations
8.
Coelho, Teresa, Julian D. Gillmore, David Adams, et al.. (2021). Open-label Study of Patisiran in Patients with hATTR Amyloidosis Post-Orthotopic Liver Transplant (2144). Neurology. 96(15_supplement). 1 indexed citations
9.
Dyck, P. James B., P. James B. Dyck, Teresa Coelho, et al.. (2020). Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis. Muscle & Nerve. 62(4). 509–515. 15 indexed citations
10.
Santos, Diana, Teresa Coelho, Miguel Alves‐Ferreira, et al.. (2019). C1QA and C1QC modify age‐at‐onset in familial amyloid polyneuropathy patients. Annals of Clinical and Translational Neurology. 6(4). 748–754. 13 indexed citations
11.
Rocha, Ana Patrícia, Hugo Miguel Pereira Choupina, Márcio Cardoso, et al.. (2019). Validation of a Single RGB-D Camera for Gait Assessment of Polyneuropathy Patients. Sensors. 19(22). 4929–4929. 28 indexed citations
12.
13.
González‐Duarte, Alejandra, David Adams, William O’Riordan, et al.. (2018). Changes in neuropathy stage in patients with hATTR amyloidosis following patisiran treatment : Analysis from APOLLO. Journal of the Peripheral Nervous System. 23(4). 400–400. 1 indexed citations
14.
15.
Adams, David, Alejandra González‐Duarte, W. O'Riordan, et al.. (2016). Burden of Illness for Patients with Hereditary Attr Amyloidosis with Polyneuropathy Begins with Symptom Onset and Increases with Disease Progression. Value in Health. 19(7). A436–A436. 3 indexed citations
16.
Coelho, Teresa, Ole B. Suhr, Isabel Conceição, et al.. (2015). Phase 2 open-label extension study of patisiran, an investigational RNAi therapeutic for the treatment of familial amyloid polyneuropathy (S9.003). Neurology. 84(14_supplement). 5 indexed citations
17.
Adams, David, Teresa Coelho, Ole B. Suhr, et al.. (2013). Interim results from phase ii trial of aln-ttr02, a novel RNAi therapeutic for the treatment of familial amyloidotic polyneuropathy. Journal of the Peripheral Nervous System. 18. 1–2. 2 indexed citations
18.
Cardoso, Márcio, Teresa Coelho, & Rajiv Mundayat. (2013). Overview of Patient Demographics and Clinical Characteristics in THAOS — The Transthyretin Amyloidosis Outcomes Survey (P05.067). Neurology. 80(7_supplement). 2 indexed citations
19.
Soares, Miguel Luz, Teresa Coelho, Alda Sousa, et al.. (2005). Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease. Human Molecular Genetics. 14(4). 543–553. 94 indexed citations
20.
Silva, Ana, Noeme Sousa Rocha, Victor Alves, et al.. (2004). Tremor as the first neurological manifestation of Sneddon's syndrome. Movement Disorders. 20(2). 248–251. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahide Yazaki Breakdown of academic impact, for papers by Toya Ohashi Breakdown of academic impact, for papers by Emil Kakkis Breakdown of academic impact, for papers by Johannes Schlöndorff Breakdown of academic impact, for papers by Gilbert J. Cote Breakdown of academic impact, for papers by Philippe M. Campeau Breakdown of academic impact, for papers by David B. Bregman Breakdown of academic impact, for papers by Wadie F. Bahou Breakdown of academic impact, for papers by Yoko Aoki Breakdown of academic impact, for papers by Terence Wu
Rankless by CCL
2026